The influence of accessibility of anticancer drug therapy on the target indicators of the oncological service

per V. V. Petkau, А. А. Karimova, S. А. Efremov, Е. А. Gruzdeva
Publicat 2021-06-01

Oncological care for the patients with hepatocellular carcinoma in COVID-19 pandemic

per V. V. Petkau, V. V. Breder, E. N. Bessonova, K. K. Laktionov, I. S. Stilidi
Publicat 2020-07-01

Interdisciplinary model of patient care for groups at risk for malignant tumors of the skin

per M. A. Ufimtseva, A. S. Shubina, V. V. Petkau, N. L. Struin, D. E. Emel'janov, E. A. Levchenko
Publicat 2019-10-01

Survival of patients with metastatic bladder cancer in the Russian Federation: results of a multicenter registry study URRU

per I. V. Tsimafeyeu, G. N. Alekseeva, V. V. Petkau, R. A. Zukov, M. S. Mazhbich, A. V. Semenov, G. B. Statsenko, O. Yu. Novikova, I. V. Zaytsev, I. L. Popova, L. I. Gurina, M. A. Mukhina, L. Yu. Vladimirova
Publicat 2021-11-01

Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study

per M.   Yu. Fedyanin, F.   V. Moiseenko, M.   A. Lyadova, V.  N.  Vorobyeva, V.  V.  Petkau, A.  V.  Fateeva, E.  S.  Kuzmina, O.  Yu.  Novikova, V.   A. Chubenko, N.  Kh.  Abduloeva, A.  A.  Kudryavtsev, E.   O. Ignatova, R.   R. Shakirov, O.  A.  Pardabekova, L.  V.  Kindyalova, S.  P.  Pelikh, O.   A. Gladkov, S.  A.  Tjulandin, A.  A.  Tryakin
Publicat 2021-06-01